BUSINESSCNBC TOP
U.S. opens tariff probe targeting Germany’s drug pricing policies
The U.S. has initiated a tariff probe targeting Germany’s drug pricing policies. U.S. Trade Representative Jamieson Greer criticized Germany’s proposal to reduce medicine spending as a 'serious step backwards.'
Mentioned
Related Signal
Adjacent reporting
- US launches Germany pharma pricing probe, raising threat of new tariffs
- STAT+: As the U.S. looks on, European countries feel growing pressure on drug prices
- STAT+: Virginia governor vetoes legislation to create an advisory panel to lower the cost of prescription drugs
- US launches trade investigation into Germany’s spending on new medicines
- Governor kills Prescription Drug Affordability Board proposal